Table of Contents
Advances in Orthopedic Surgery
Volume 2014 (2014), Article ID 572586, 4 pages
http://dx.doi.org/10.1155/2014/572586
Research Article

Evaluation of Amniotic-Derived Membrane Biomaterial as an Adjunct for Repair of Critical Sized Bone Defects

1Department of Orthopaedic Surgery, North Shore/LIJ Health System, 300 Community Drive, Manhasset, NY 11030, USA
2Orthopaedic Research Laboratory, Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA

Received 12 September 2013; Accepted 9 March 2014; Published 2 April 2014

Academic Editor: Vinod K. Panchbhavi

Copyright © 2014 Mikael Starecki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Introduction. Autogenous bone graft is the gold standard in reconstruction of bone defects. The use of autogenous bone graft is problematic because of limited bone as well as donor site morbidity. This study evaluates a novel biomaterial as an alternative to autogenous bone graft. The biomaterial is amniotic membrane, rich in growth factors. Methods. Twenty-one adult male Sprague-Dawley rats were implanted with biomaterial using the rat critical size femoral gap model. After creation of the critical size femoral gap animals were randomized to one of the following groups: Group 1 (control): gap left empty and received no treatment; Group 2 (experimental): the gap was filled with commercially available bone graft; Group 3 (experimental): the gap was filled with bone graft plus NuCel amniotic tissue preparation. Results. The experimental groups demonstrated new bone formation compared to controls. The results were evident on radiographs and histology. Histology showed Group 1 controls to have 11.1% new bone formation, 37.8% for Group 2, and 49.2% for Group 3. These results were statistically significant. Conclusions. The study demonstrates that amniotic membrane products have potential to provide bridging of bone defects. Filling bone defects without harvesting autogenous bone would provide a significant improvement in patient care.